First, I'm on the steering committee, so I'm not formally employed by either the Department of Veteran Affairs or Open Arms, but I sit very much as an external adviser on that committee and part of the team that has formulated how that program should look.
It would hardly be applicable. It would be immediately transferable. It's a treatment design program that aims to give an assessment and treatment strategy for personnel who suffer from any kind of neurocognitive, neurological disorder. So it's not necessarily specific only to mefloquine and tafenoquine veterans in Australia, but can take account of more broadly acquired brain injury in mild traumatic brain injury or degenerative brain conditions for all the veterans as well.
It would be easily transferable to any other jurisdiction.